Question

(1)

(b) Option (2) (c) Option (3)

(d) Option (4)

Question No.-2

Read the passage given below.

The incidence of dengue has grown dramatically around the world in recent decades. A vast majority of cases are asymptomatic or mild and self-managed, and hence the actual numbers of dengue cases are under-reported or often misdiagnosed.

One estimate indicates 390 million dengue virus infections per year (95% credible interval 284-528 million), of which 96 million (67-136 million) manifest clinically (with any severity of disease). The number of dengue cases reported to WHO increased over 8 fold over the last two decades. This alarming increase in case numbers is partly explained by a change in national practices to record and report dengue to the Ministries of Health, and to the WHO. But it also represents government recognition of the burden, and therefore the pertinence to report dengue disease. Before 1970, only 9 countries had experienced severe dengue epidemics. The disease is now endemic in more than 100 countries in the WHO regions of Africa, the Americas, the Eastern Mediterranean, South

East Asia and the Western Pacific. The America. South-East Asia and Western Pacific regions are the most seriously affected, with Asia representing -70% of the global burden of disease. In 2020, dengue continues to affect several countries, with reports of increases in the numbers of cases in Bangladesh, Brazil, Cook Islands, Ecuador. India, Indonesia, Maldives, Mauritania, Mayotte (Fr), Nepal, Singapore, Sri Lanka, Sudan, Thailand Timor-Leste and Yemen.

Dengue Cases (2013-2020)

The largest number of dengue cases ever reported globally was in 2019. All regions were affected, and

dengue transmission was recorded in Afghanistan for the first time.

The first dengue vaccine, Dengvaxia (CYD-TDV) developed by Sanofi Pasteur was licensed in

December 2015 and has now been approved by regulatory authorities in -20 countries. In November

2017, the results of an additional analysis to retrospectively determine serostatus at the time of vaccination were released. As described in the WHO position paper on the Dengvaxia vaccine (September 2018) the dengue vaccine CYD-TDV has been shown in clinical trials to be efficacious and safe in persons who have had a previous dengue virus infection. However, it carries an increased risk of severe dengue in those who experience their first natural dengie infection after vaccination. For countries considering vaccination as part of their dengue control programme, pre-vaccination screening is the recommended strategy

On the basis of your understanding of the passage attempt ANY TEN questions from the twelve that follow. (1x10-10)

4 In the line, and therefore the pertinence to report dengue disease, the word pertinence does

not mean a. Importance

b. Ignorance

c. Relevance 4. Appropriateness

According to the WHO report, around 70% of the dengue cases from around the world.

a. Affect people in Asia

b. Misdiagnosed in Asia

c. Do not occur in Asia

d d. Remain untreated in Asia​

Answer 1

Answer:

option2

may be write answers

Explanation:

y what happened